DNA Methylation in Endocrine Therapy Resistant Breast Cancer

被引:0
|
作者
Jawale, Rahul
Williams, Kristin
Yang, Howard
Lee, Maxwell
Otis, Christopher
Pentecost, Brian
Arcaro, Kathleen
机构
[1] Baystate Med Ctr, Springfield, MA USA
[2] UMass Amherst, Amherst, MA USA
[3] Wadsworth Ctr, Albany, NY USA
[4] NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1837
引用
收藏
页码:458A / 459A
页数:2
相关论文
共 50 条
  • [1] DNA Methylation in Endocrine Therapy Resistant Breast Cancer
    Jawale, Rahul
    Williams, Kristin
    Yang, Howard
    Lee, Maxwell
    Otis, Christopher
    Pentecost, Brian
    Arcaro, Kathleen
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 458A - 459A
  • [2] Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer
    Stone, Andrew
    Valdes-Mora, Fatima
    Clark, Susan J.
    [J]. EPIGENOMICS, 2013, 5 (06) : 595 - 598
  • [3] Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer
    Martens, JWM
    Nimmrich, I
    Koenig, T
    Look, MP
    Harbeck, N
    Model, F
    Kluth, A
    Bolt-De Vries, J
    Sieuwerts, AM
    Portengen, H
    Gelder, MEM
    Piepenbrock, C
    Olek, A
    Höfler, H
    Kiechle, M
    Klijn, JGM
    Schmitt, M
    Maier, S
    Foekens, JA
    [J]. CANCER RESEARCH, 2005, 65 (10) : 4101 - 4107
  • [4] Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions
    Zhang, Fan
    Cui, Yukun
    [J]. ONCOLOGY LETTERS, 2019, 18 (02) : 1287 - 1303
  • [5] Elucidation of molecular network associated with endocrine therapy resistant breast cancer
    Horie, Kuniko
    [J]. CANCER SCIENCE, 2018, 109 : 15 - 15
  • [6] Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors
    Nakao, Mitsuyoshi
    Fujiwara, Saori
    Iwase, Hirotaka
    [J]. TRENDS IN CANCER, 2018, 4 (06): : 404 - 407
  • [7] Adaptive kinome reprogramming in endocrine therapy resistant metastatic breast cancer
    Dustin, Derek
    Gu, Guowei
    Chan, Doug
    Beyer, Amanda
    Edwards, David
    Ellis, Matthew
    Fuqua, Suzanne
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [8] FASN inhibition as a potential treatment for therapy of endocrine resistant breast cancer
    Gruslova, A.
    Sareddy, G. R.
    Vadlamudi, R. K.
    Viswanadhapalli, S.
    Brenner, A.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] DNA methylation in breast cancer
    Yang, X
    Yan, L
    Davidson, NE
    [J]. ENDOCRINE-RELATED CANCER, 2001, 8 (02) : 115 - 127
  • [10] DNA methylation and breast cancer
    Szyf, M
    Pakneshan, P
    Rabbani, SA
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1187 - 1197